Abstract:Peiqiu Zhu, 1 Weiwei Deng 2 1 Department of Dermatology and Venereology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, People's Republic of China Correspondence: Weiwei Deng, Department of Dermatology, Dermatology Hospital of Southern Medical University, Guangzhou, People's Republic of China, Tel +86 15622165048, Email Background: Systemic sclerosis represents a persistent autoimmune disorder marked with fibrosis affecting both skin and other organs, which leads to a diminished quality of life and increased mortality. The affected skin provides a valuable opportunity to explore the pathogenesis of systemic sclerosis. Nevertheless, the roles of various cell populations within scleroderma remain intricate. Methods: We conducted a comprehensive reanalysis of recently published single-cell RNA-sequencing data from skin tissue cells in scleroderma. Through the utilization of Seurat, irGSEA, AUCell packages, and WGCNA analysis, we aimed to unveil crucial genes associated with the disease's etiological factors. Our investigation involved the characterization of heterogeneous pathway activities in both healthy and SSc-affected skin. Furthermore, we employed immunofluorescence techniques to validate the expression patterns of hub genes and differentially expressed genes. Results: The Endothelial-to-Mesenchymal Transition (EndMT) pathway was upregulated in SSc skin. Notably, the M4 module within Endothelial cell subpopulation 1 exhibited a strong association with EndMT. Furthermore, we identified three overexpressed genes ( APLNR , I NS-IGF2, RGCC ) that demonstrated a significant correlation with EndMT. Importantly, their expression levels were markedly higher in skin of individuals with SSc when compared to healthy controls. Conclusion: APLNR, INS-IGF2 and RGCC serve as potential key players in the pathogenesis of SSc skin through EndMT-dependent mechanisms. Keywords: systemic sclerosis skin, single cell RNA-sequencing analysis, the Endothelial to Mesencchymal Transition, EndMT, APLNR , INS-IGF2 , RGCC As a sort of uncommon connective tissue disorder, scleroderma is distinguished by cutaneous sclerosis and variable systemic involvement. 1 There are 2 main forms of systemic sclerosis(SSc): localized scleroderma (LS), also known as limited cutaneous SSc, and diffuse SSc. 2 It is currently believed that patients who develop SSc have an underlying genetic predisposition to these conditions and are subsequently exposed to environmental factors that initiate inflammatory and fibrotic processes. 3 The common clinical manifestations of SSc encompass skin fibrosis, digital vascular ulcers, arrhythmias in involvement with the cardiovascular system, pulmonary fibrosis, pulmonary artery hypertension, fibrotic changes in the gastrointestinal tract, endothelial cell injury in the kidneys, and even hand (finger) flexion contractures. 4 Evaluation of sclerotic skin reveals thickened and homogenized collagen bundles in both superficial and middle dermis. 5 Qualitative SSc nailfold capillary number has been developed to accurately determine capillary absolute number and density from nail-fold video capillaroscopy images, which has been successfully validated in patients diagnosed with systemic sclerosis (SSc). 6 Etiological factors trigger the activation of keratinocytes, T cells, and the production of various components that contribute to fibrosis. These factors induce fibroblast proliferation through toll-like receptor 4 (TLR-4) by enhancing the activity of transforming growth factor β (TGF-β). 7 A preliminary study, albeit with a small number of cells and samples, suggested that inhibiting TGF-β1 signaling might be one of the most promising approaches to treat skin fibrosis in scleroderma. 8 In recent years, while the role of the TGF-β family in the pathogenesis of LS has been confirmed, the signal pathways and molecular process involved are too complex to fully elucidate. Consequently, investigating the molecular mechanisms within different types of cells, cytokines, and extracellular matrix (ECM) components can help uncover what lies beneath the surface. Several studies have provided evidence supporting the involvement of endothelial cells (EC) in endothelial-to-mesenchymal transition (EndMT), a recently acknowledged form of cellular trans-differentiation. Involved in crucial embryonic development processes, EndMT assumes a significant role in the development of various genetically determined and acquired human diseases, including -Abstract Truncated-

The c-Rel subunit of NF-κB regulates epidermal homeostasis and promotes skin fibrosis in mice

Lysyl Oxidase Enzymes Mediate TGF-β1-induced Fibrotic Phenotypes in Human Skin-Like Tissues

Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma

Nrf2 in Keratinocytes Protects Against Skin Fibrosis Via Regulating Epidermal Lesion and Inflammatory Response.

Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin

Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders

The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis

Atypical Chemokine Receptor 1-Positive Endothelial Cells Mediate Leucocyte Infiltration and Synergize with Secreted Frizzled-Related Protein 2/Asporin-Positive Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.

A role for FcγRIIB in the development of murine bleomycin-induced fibrosis

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis

Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-κB p105/p50 in chronic inflammatory skin diseases

An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

Single-Cell RNA-Sequencing Analyses Identify APLNR, INS-IGF2, RGCC Genes May Be Involved in the Pathogenesis of Systemic Sclerosis Skin

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

NF-κB signaling in skin aging

NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation

Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin

The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response

The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function

The transcription regulators ZNF750 and LSD1/KDM1A dampen inflammation on the skin's surface by silencing pattern recognition receptors

The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation